Literature DB >> 13954440

Polymorphism and drug availability. Solubility relationships in the methylprednisolone system.

W I HIGUCHI, P K LAU, T HIGUCHI, J W SHELL.   

Abstract

Entities:  

Keywords:  METHYLPREDNISOLONE

Mesh:

Substances:

Year:  1963        PMID: 13954440     DOI: 10.1002/jps.2600520210

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Ritonavir: an extraordinary example of conformational polymorphism.

Authors:  J Bauer; S Spanton; R Henry; J Quick; W Dziki; W Porter; J Morris
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Pharmaceutical solids: a strategic approach to regulatory considerations.

Authors:  S Byrn; R Pfeiffer; M Ganey; C Hoiberg; G Poochikian
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

4.  Estimating the Aqueous Solubility of Pharmaceutical Hydrates.

Authors:  Stephen J Franklin; Usir S Younis; Paul B Myrdal
Journal:  J Pharm Sci       Date:  2016-06       Impact factor: 3.534

5.  Solid-state properties of tobramycin.

Authors:  A K Dash; R Suryanayanan
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.